PsiThera

Promakhos

This company develops oral small-molecule immunotherapies that restore immune system function to treat patients with chronic inflammatory diseases.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.

Orogen Therapeutics

Orogen Therapeutics develops small-molecule drugs for autoimmune and immuno-inflammatory diseases using an AI-enabled DNA-encoded library platform to identify novel chemical matter for patients.

Aizen Therapeutics

This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

Sightera

Sightera develops an artificial intelligence platform for drug discovery to design small-molecule therapies for oncology and fibrosis patients.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Sitryx Therapeutics

The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.